WHAT IS CELL & GENE THERAPY? WHY IS IT IMPORTANT?

Cell and gene therapies for cancer are treatments that attack only cancer cells. This approach has the potential to replace traditional treatments that can cause adverse side effects on the body. Learn more...

ACGT FELLOW'S RESEARCH OBLITERATES TUMORS IN LEUKEMIA PATIENTS

Dr. Carl June and his team at University of Pennsylvania Abramson Cancer Center are making great strides for the treatment of advanced CLL (chronic lymphocytic leukemia). The clinical trial, funded by ACGT, uses genetically modified versions of the patient's own T cells, and has shown remission for up to a year in a small group of patients, several of whom are in complete remission.
January 2012 - Science Translational Magazine has honored this research as "Paper of the Year 2011".

THE STORY WAS COVERED BY NBC NIGHTLY NEWS ON AUG 10, 2011

• Read more about Dr. June and his research
• View the video featuring the University of Pennsylvania scientists
• Read one clinical trial patient's experience on the University of Pennsylvania web site

PHACILITATE'S CELL & GENE THERAPY 2012 FORUM
January 30 - February 1, 2012 Washington, D.C.

NOBEL PRIZE FOR IMMUNOTHERAPY:
DISCOVERIES THAT PAVED THE WAY FOR CELL AND GENE THERAPY!

Every day, ACGT Grantees are making enormous progress in the treatments of Lymphoma, Leukemia, Multiple Myeloma, Neuroblastoma, Breast cancer, Ovarian cancer, Lung cancer, Brain cancer, Pancreatic cancer, and Prostate cancer.
View a list of our Grantees.

ACGT is leading the way in bringing molecular medicine directly to patients with more than 17 clinical trials underway. Now, more than ever, we need your support to continue to fund this breakthrough cancer research.
Please donate now.